Ayurveda targeting global markets; seeks govt support to maintain momentum

# Ayurveda's Global Win — But India's Still Not Free From Pharma's Grip

India's oldest science is finally getting global recognition. But the moment it threatens the trillion-dollar pharmaceutical empire, the rules of "evidence" mysteriously change.

What Actually Happened

The Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy (AYUSH) is pushing Ayurvedic exports with renewed aggression. WHO recognition in 2019 opened doors. Europe is now demanding Indian Ayurvedic formulations. Japan, Australia, Singapore — all waiting. But export volumes remain stuck because of regulatory roadblocks and — let's be honest — because the global pharmaceutical lobby doesn't want Indian root-cause medicine competing with their symptom-management pills.

The Indian government is now seeking support to streamline approvals, standardize production, and protect intellectual property of traditional formulations. Sounds good on paper. But here's the reality: while AYUSH ministry talks, the same governments that recognize Ayurveda demand "clinical evidence" standards so expensive that only pharma companies can afford them. A turmeric trial costs ₹5 crore. A drug trial for a new synthetic molecule? Same price. But one gets funded. Guess which one.

What This Means for India

We are sitting on a ₹100,000 crore opportunity and acting like a beggar at the gate. Ayurveda is not fringe medicine anymore. It's validated by the world's largest medical body. But India's response? Slower approvals, less R&D funding, and zero aggressive marketing.

The pattern is clear: India discovered the formula but lost the narrative. We let the West define what is "scientific." We let pharma define what counts as "evidence." When a German university validates ashwagandha for stress, suddenly it becomes credible. When an Indian Vaid uses it for 3,000 years — it's "anecdotal."

This is the Bharat Decoded moment. We need to stop seeking permission from Western regulators and start building our own standards, our own trials, our own export ecosystem. We have the science. We have the market demand. What we don't have is institutional confidence to move without a foreigner's approval stamp.

The Deeper Story Nobody is Telling

The pharmaceutical industry doesn't fear Ayurveda because it's weak. It fears it because it works on root causes. And that's a threat to recurring revenue.

Consider this: A person with Type 2 diabetes on metformin pays ₹50,000 yearly for life. No cure. Just management. The same person on a structured Ayurvedic protocol addressing insulin resistance, gut dysbiosis, and pancreatic inflammation? Recovery within 6-12 months. Cost: ₹8,000 to ₹15,000 total. Then he's done.

Multiply that across thyroid disorders, asthma, autoimmune diseases, and cancer recovery. Ayurveda doesn't sell perpetual dependence. It sells return to health. That's why it's blocked at every regulatory turn. The system isn't designed to cure you. It's designed to manage you.

When India exports Ayurveda without fighting the narrative war, we're just shipping raw materials to be repackaged and sold back as "Western-validated wellness." We did this with spices, with tea, with cotton. We're doing it again with medicine.

What This Means for Your Health

First: Stop waiting for government permission to heal. Ayurveda works. The fact that the WHO recognizes it after 5,000 years tells you something about how long institutional medicine takes to catch up. Use it. Your body doesn't need a certificate to respond to turmeric, neem, ashwagandha.

Second: Understand root causes. Acidity, inflammation, toxins, parasitic load — these are the foundations of chronic disease in the Indian body. Modern medicine treats symptoms. Ayurveda removes causes. One costs ₹50,000 yearly. The other ₹8,000 once. Do the math.

Third: Find a qualified practitioner, not a supplement seller. Ayurveda is a system, not a shopping list. A proper protocol considers your prakruti, your dosha imbalance, your specific disease root. This isn't generalized wellness. This is medicine.

The global market recognizes what Indians forgot: our medicine is superior for chronic disease prevention and recovery. The only question now is whether we'll commercialize it under foreign permission or build our own standards.

Follow BHARAT DECODED on Telegram: t.me/DecodedByRDS

Rajnish Sharma (RDS)